In contrast to lung cancer,31 where promoter hypermethylation of this gene in transformed cells was associated with gene silencing, we observed that promoter hypomethylation of MYO18B was associated with upregulation of gene expression in a set of CIMP+ T‐ALL samples. The gene discussed is MYO18B; the disease is lung carcinoma.